Retatrutide Dosage: Clinical Trial Doses and Titration

Retatrutide dosage in clinical trials has ranged from 1 mg to 12 mg once weekly, with a slow titration schedule to minimize side effects. However, retatrutide is not FDA-approved for human use, so there is no official recommended dose. All known dosing information comes from investigational research studies.

What Is Retatrutide?

Retatrutide is an experimental triple agonist that targets GIP, GLP-1, and glucagon receptors. It is being developed by Eli Lilly for obesity and type 2 diabetes. The glucagon component may increase energy expenditure, while GLP-1 and GIP reduce appetite. The drug is not yet approved by the FDA, so any retatrutide dosing information is based on clinical trial protocols, not medical guidance.

Because retatrutide remains investigational, researchers and the public often search for terms like retatrutide dose, retatrutide dosing schedule, and retatrutide protocol reddit. Online anecdotes, however, are not a substitute for clinical data.

Retatrutide Dosing in Clinical Trials

The Phase 2 trial tested several weekly doses. Participants started at a low dose and increased every 4 weeks. Higher doses produced greater weight loss, but also more gastrointestinal side effects.

Dose group	Titration schedule	Maintenance dose
1 mg	No titration	1 mg weekly
4 mg	2 mg for 4 weeks	4 mg weekly
8 mg	2 mg for 4 weeks, then 4 mg for 4 weeks	8 mg weekly
12 mg (slow)	2 mg for 4 weeks, 4 mg for 4 weeks, 8 mg for 4 weeks	12 mg weekly
12 mg (fast)	4 mg for 4 weeks, 8 mg for 4 weeks	12 mg weekly

Retatrutide 12 mg was the highest dose studied. A 40 mg retatrutide dose has not been tested in human trials. Vials labeled retatrutide 5mg, retatrutide 10 vial kit, or retatrutide 30 are sold for research purposes only, not for human use.

Retatrutide Titration Schedule

Titration means starting low and going slow. This retatrutide titration schedule helps the body adjust and reduces nausea, vomiting, and diarrhea. In trials, each dose step lasted at least 4 weeks.

A typical retatrutide titration schedule might look like this: 2 mg for 4 weeks, then 4 mg for 4 weeks, then 8 mg for 4 weeks, then 12 mg. Some people search for a retatrutide titration schedule reddit, but online forums are not reliable sources for medical dosing.

How often to take retatrutide? In studies, it is once weekly. How much retatrutide per week? The maintenance dose ranged from 1 mg to 12 mg per week. There is no established retatrutide cycle length outside research, and how long to take retatrutide depends on the trial design.

How to Take Retatrutide: Injection, Timing, and Units

Retatrutide is given as a once-weekly subcutaneous injection. It is not a pill. The injection goes into the abdomen, thigh, or upper arm. Rotate sites to avoid irritation. If you miss a weekly dose, trials typically instruct participants to take it as soon as possible, then resume the regular schedule.

Many people ask how to inject retatrutide or how to take retatrutide. In trials, the same day each week is recommended, but the time of day does not matter. The best time to take retatrutide morning or night has not been shown to make a difference. You can take retatrutide at night if that is more convenient.

If using a research peptide, a retatrutide calculator can convert mg to units on an insulin syringe. For example, a 10 mg retatrutide vial mixed with 1 mL of water gives 10 mg/mL. A 0.5 mg dose would be 5 units on a U-100 syringe. A 2.5 mg dose would be 25 units. How many units of retatrutide should I take depends entirely on the vial concentration and your target dose.

But self-dosing with research chemicals is risky and not recommended. There is no FDA-approved retatrutide product, so any retatrutide 10 mg, retatrutide 12 mg, or retatrutide 24 mg vial is not intended for human consumption.

Retatrutide Cycle and Duration

Clinical trials of retatrutide have run for 24 to 48 weeks. A retatrutide cycle in research typically lasts several months. How long should I take retatrutide? That question cannot be answered outside a clinical trial.

Some users discuss a retatrutide cycle length on forums, but no safety or efficacy data supports long-term self-administration. Retatrutide is not approved for weight loss, diabetes, or any other condition.

Retatrutide Dose Comparisons and Other Peptides

Retatrutide is often compared to other weight-loss drugs. A common search is cagrilintide vs retatrutide vs tirzepatide, but each has a different mechanism. Cagrilintide dosage is not the same as retatrutide dosage.

Some experimenters stack peptides, such as aod 9604 and retatrutide, but no safety data supports this. For sleep studies, dsip 5mg dosage is sometimes discussed, and kisspeptin-10 dosage is used in reproductive research. These are unrelated to retatrutide dosing.

Safety and Side Effects

Common side effects in trials include nausea, diarrhea, vomiting, and constipation. Some participants had increased heart rate. Retatrutide is not safe for everyone, especially those with a history of pancreatitis or thyroid cancer.

Retatrutide is not FDA-approved for human use in the United States. Anyone considering retatrutide should consult a licensed healthcare professional first. Never use research chemicals for human consumption.

COMMON QUESTIONS

Frequently Asked Questions

How much retatrutide do you take per week?

In clinical trials, retatrutide was taken once weekly at doses ranging from 1 mg to 12 mg. The dose was increased slowly over several weeks. Retatrutide is not FDA-approved, so there is no official weekly dose.

How often should I take retatrutide?

Retatrutide is injected once weekly in clinical trials. The same day each week is recommended to keep blood levels steady. There is no approved schedule for human use outside research.

What is the best time to take retatrutide morning or night?

Clinical trials did not specify a time of day for retatrutide injections. Morning or night does not appear to affect efficacy. Choose a time you can remember and stick to it consistently.